Creative Biolabs ADC Blog

Menu

Skip to content
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News

Category Archives: Review

13Oct/20

Design ADC with Creative Biolabs – Episode II

October 13, 2020Reviewadc Conjugate, ADC design, antibody of ADCbioadc

In the last blog, we learned that the main feature of ADC candidate target antigen is that it needs to be highly expressed on the surface of tumor cells and not expressedRead More…

17Sep/20

Design ADC with Creative Biolabs-Episode I

September 17, 2020ReviewADC design, DAR, tumor targetbioadc

As we all known, antibody-drug conjugate (ADC) is a drug obtained by chemical conjuagtion of antibody, linker and cytotoxin. Compared with simple monoclonal antibodies, ADC has better targeting and more efficient killingRead More…

Posts navigation

  • « Previous
  • 1
  • …
  • 4
  • 5
  • 6

Categories

Recent Posts

  • Antibody Discovery Targeting S. aureus Virulence Antigens
  • Bioconjugation Strategies for Antibody-Antibiotic Conjugates
  • Engineering Smarter Payloads: The Rise of Next-Generation Bispecific ADC Strategies
  • Beyond Single Targets: How Bispecific ADCs Are Redefining Precision Oncology
  • The Next Frontier in Oncology: Why Bispecific ADCs are Redefining Precision Medicine

Archives

Contact Us

USA - UK

Copyright © Creative Biolabs ADC Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News